Visure Solutions

Start Free Trial

Quality Management System (QMS) For Pharmaceutical

Table of Contents


The pharmaceutical industry plays a critical role in global health by developing and producing medications that improve and save lives. Given the sensitive nature of pharmaceutical products and the potential impact on public health, ensuring quality throughout the entire product lifecycle is paramount. A well-designed and effectively implemented Quality Management System (QMS) is essential for pharmaceutical companies to meet regulatory requirements, maintain product safety, and enhance overall efficiency.

Importance of Quality Management in Pharmaceuticals

Quality management in the pharmaceutical industry is of paramount importance due to its direct impact on public health, regulatory compliance, and the overall success of pharmaceutical companies. Here are several key reasons highlighting the significance of quality management in the pharmaceutical sector:

  • Patient Safety and Efficacy: The primary objective of any pharmaceutical product is to improve or maintain patient health. Quality management ensures that medications are safe, effective, and reliable. Rigorous quality control measures are in place to minimize the risk of adverse effects and ensure the desired therapeutic outcomes.
  • Regulatory Compliance: The pharmaceutical industry is heavily regulated by health authorities globally, such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and others. Adherence to Current Good Manufacturing Practice (cGMP) regulations is mandatory. A robust quality management system ensures compliance with these regulations, preventing legal and financial consequences for non-compliance.
  • Product Consistency: Quality management systems help maintain consistency in manufacturing processes, ensuring that each batch of a pharmaceutical product meets predetermined specifications. This consistency is crucial for achieving uniform product quality, which is vital for both regulatory compliance and building trust among healthcare professionals and patients.
  • Risk Mitigation: The pharmaceutical manufacturing process involves numerous variables, and deviations can occur at any stage. Quality management incorporates risk assessment and mitigation strategies, identifying potential issues before they escalate. This proactive approach minimizes the likelihood of defects, recalls, and adverse events, protecting both patients and the company’s reputation.
  • Supply Chain Integrity: Pharmaceutical companies rely on complex global supply chains for raw materials and components. A robust quality management system includes supplier and vendor management processes to ensure the integrity of incoming materials. This is critical for preventing contamination, counterfeiting, or substandard components that could compromise the quality of the final product.
  • Continuous Improvement: Quality management is not a one-time process; it involves a commitment to continuous improvement. By regularly assessing and optimizing processes, pharmaceutical companies can identify areas for enhancement, increase efficiency, and adapt to emerging technologies. This ongoing commitment to improvement is essential for remaining competitive in the industry.
  • Brand Reputation: The reputation of a pharmaceutical company is closely tied to the quality of its products. A single quality-related incident, such as a product recall or safety concern, can have lasting repercussions on a brand’s reputation. Quality management helps safeguard a company’s image by prioritizing the consistent delivery of safe and effective products.
  • Cost Savings: While implementing and maintaining a quality management system requires an initial investment, it can lead to long-term cost savings. By reducing the likelihood of recalls, rejections, and legal consequences associated with poor quality, companies can avoid significant financial losses. Additionally, an efficient QMS contributes to streamlined processes and resource optimization.
  • Global Competition: In an increasingly globalized pharmaceutical market, companies must meet international quality standards to compete effectively. A strong QMS ensures that products not only meet local regulations but also align with international guidelines, enabling pharmaceutical companies to expand their market presence.
  • Adaptation to Industry Trends: The pharmaceutical industry is dynamic, with constant advancements in technology, manufacturing processes, and regulatory requirements. Quality management systems enable companies to adapt to these changes seamlessly, ensuring that they remain at the forefront of innovation while maintaining compliance with evolving industry standards.

Regulatory Framework for Pharmaceutical QMS

The regulatory framework for Quality Management Systems (QMS) in the pharmaceutical industry is a complex and comprehensive set of guidelines and standards established by regulatory authorities worldwide. These regulations are designed to ensure the safety, efficacy, and quality of pharmaceutical products. The two primary regulatory bodies that influence the pharmaceutical QMS are the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). However, many other countries and regions have their own regulatory agencies with similar requirements.

Current Good Manufacturing Practice (cGMP)

Definition: Current Good Manufacturing Practice, commonly known as cGMP, is a set of regulations and guidelines that outline the principles and practices required for the manufacturing of pharmaceutical products.

Key Components:

  • Facilities and Equipment: cGMP regulations specify requirements for the design, construction, and maintenance of facilities and equipment used in pharmaceutical manufacturing. This includes ensuring that facilities are suitable for their intended purpose and that equipment is properly calibrated and maintained.
  • Personnel: Regulations define the qualifications, training, and responsibilities of personnel involved in the manufacturing process. This includes requirements for training programs to ensure that employees are competent in their roles.
  • Documentation and Recordkeeping: A robust documentation system is a fundamental aspect of cGMP. This includes the creation and maintenance of written procedures (Standard Operating Procedures or SOPs), records, and documentation related to the manufacturing process.
  • Production and Process Controls: cGMP regulations emphasize the need for effective controls over the manufacturing process to ensure product quality. This involves monitoring critical parameters, conducting in-process testing, and implementing measures to prevent deviations.
  • Testing and Release of Products: Quality control testing is a crucial element of cGMP, ensuring that each batch of pharmaceutical products meets established specifications before release. This includes testing for identity, strength, purity, and other relevant characteristics.
  • Handling of Deviations and Complaints: Regulations require the establishment of procedures for handling deviations from established processes and addressing customer complaints. An effective Corrective and Preventive Actions (CAPA) system is crucial for continuous improvement.

International Council for Harmonisation (ICH) Guidelines

The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global organization that brings together regulatory authorities and the pharmaceutical industry to develop international guidelines. The ICH guidelines complement and harmonize regulatory requirements across regions.

Key ICH Guidelines Relevant to QMS:

  • ICH Q7 – Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients: Provides guidance on GMP for the manufacturing of active pharmaceutical ingredients (APIs).
  • ICH Q8 – Pharmaceutical Development: Focuses on the development of a pharmaceutical product, emphasizing the need for a comprehensive understanding of the product and the processes involved.
  • ICH Q9 – Quality Risk Management: Highlights the importance of risk management in the pharmaceutical industry and encourages the integration of risk management principles into the QMS.
  • ICH Q10 – Pharmaceutical Quality System: Outlines the elements of a pharmaceutical quality system and emphasizes the importance of a quality management approach throughout the product lifecycle.

Local Regulatory Requirements

In addition to cGMP and ICH guidelines, pharmaceutical companies must adhere to specific regulations imposed by local regulatory authorities in the countries where they operate. These regulations may include additional requirements and variations based on regional considerations.

Key Aspects of Local Regulatory Requirements:

  • Marketing Authorization: Companies must obtain marketing authorization from regulatory agencies before distributing pharmaceutical products. This involves submitting detailed documentation on the quality, safety, and efficacy of the product.
  • Inspections: Regulatory authorities conduct inspections to ensure compliance with local regulations and international standards. Companies must be prepared for both routine and unannounced inspections.
  • Pharmacovigilance: Companies are required to have systems in place for monitoring and reporting adverse drug reactions (ADR) and other safety-related information.
  • Labeling and Packaging: Local regulations specify requirements for product labeling and packaging to ensure clear and accurate information for healthcare professionals and patients.

Key Components of a Pharmaceutical QMS

A Pharmaceutical Quality Management System (QMS) is a comprehensive framework designed to ensure that pharmaceutical products consistently meet quality standards, regulatory requirements, and patient expectations. The QMS encompasses various elements that collectively contribute to the planning, implementation, and continuous improvement of quality throughout the entire product lifecycle. Here are the key components of a Pharmaceutical QMS:

Document Control

Objective: To establish and maintain a systematic approach for the creation, review, approval, distribution, and revision of documents related to the pharmaceutical quality system.

Key Activities:

  • Document creation and approval processes.
  • Version control and document distribution.
  • Regular review and update of documents.
  • Document retrieval and archival.

Change Control

Objective: To manage and control changes to systems, processes, procedures, and documents that may impact product quality, safety, or efficacy.

Key Activities:

  • Identification and documentation of proposed changes.
  • Impact assessment and risk analysis.
  • Change approval and implementation.
  • Verification of the effectiveness of implemented changes.

Risk Management

Objective: To systematically identify, assess, control, and monitor risks associated with the development, manufacturing, and distribution of pharmaceutical products.

Key Activities:

  • Risk identification and assessment.
  • Risk mitigation and control strategies.
  • Monitoring and updating risk assessments.
  • Integration of risk management into decision-making processes.

Corrective and Preventive Actions (CAPA)

Objective: To address and rectify deviations, non-conformities, and incidents, and to implement measures to prevent their recurrence.

Key Activities:

  • Incident investigation and root cause analysis.
  • Development and implementation of corrective actions.
  • Monitoring and verification of corrective actions.
  • Proactive identification and implementation of preventive actions.

Training and Competence Management

Objective: To ensure that personnel have the necessary skills, knowledge, and competencies to perform their roles effectively in the pharmaceutical manufacturing process.

Key Activities:

  • Training needs assessment.
  • Development and delivery of training programs.
  • Competence assessment and periodic reviews.
  • Documentation of training records.

Supplier and Vendor Management

Objective: To ensure the quality and integrity of raw materials, components, and services provided by suppliers and vendors.

Key Activities:

  • Supplier qualification and evaluation.
  • Establishment of quality agreements.
  • Monitoring and auditing of suppliers.
  • Handling deviations and non-conformities related to suppliers.

Product Quality Review (PQR)

Objective: To evaluate the overall quality and performance of pharmaceutical products on a periodic basis.

Key Activities:

  • Collection and analysis of relevant data.
  • Assessment of product quality trends.
  • Identification of opportunities for improvement.
  • Documentation and reporting of PQR results.

These key components collectively form the foundation of a robust Pharmaceutical QMS, providing a systematic and integrated approach to quality assurance. It’s important to note that the implementation of these components is not a one-time effort but requires ongoing commitment to continuous improvement, compliance with regulations, and adaptation to emerging industry trends. A well-functioning QMS contributes to the production of safe, effective, and high-quality pharmaceutical products, ultimately benefiting patients and maintaining the integrity of the pharmaceutical industry.

Implementing and Maintaining a Pharmaceutical QMS

Implementing and maintaining a Pharmaceutical Quality Management System (QMS) is a multifaceted process that requires commitment from leadership, the integration of standardized processes, and continuous monitoring and improvement. A well-established QMS ensures that pharmaceutical companies consistently produce safe, effective, and high-quality products while meeting regulatory requirements. Here are key steps and considerations for implementing and maintaining a Pharmaceutical QMS:

Leadership and Commitment:

  • Leadership Involvement: Top management must demonstrate a clear commitment to quality. This involves allocating resources, defining quality objectives, and fostering a culture of quality throughout the organization.
  • Establishing a Quality Policy: Develop a quality policy that reflects the organization’s commitment to meeting regulatory requirements and ensuring continuous improvement in product quality.

Process Mapping and Optimization:

  • Identify Key Processes: Map out key processes within the pharmaceutical manufacturing lifecycle, from product development to distribution. This includes manufacturing, quality control, change control, and other critical processes.
  • Optimization: Identify areas for improvement in existing processes. Process optimization can lead to increased efficiency, reduced waste, and enhanced overall product quality.

Technology Integration:

  • Electronic Document Management: Implement electronic document management systems to streamline the creation, approval, and distribution of documents, ensuring version control and accessibility.
  • Computerized Systems Validation: Validate computerized systems used in the manufacturing process to ensure data accuracy, reliability, and compliance with regulatory requirements.

Continuous Monitoring and Auditing:

  • Internal Audits: Conduct regular internal audits to ensure compliance with established processes and identify areas for improvement. Internal audits help prepare for external regulatory inspections.
  • Monitoring and Metrics: Establish key performance indicators (KPIs) and metrics to monitor the effectiveness of the QMS. This may include metrics related to product quality, deviations, and corrective actions.

Data Integrity and Security:

  • Data Management: Implement robust data management practices to ensure the integrity and security of data throughout the product lifecycle. This is critical for compliance with regulatory requirements.
  • Access Controls: Implement access controls to restrict access to sensitive data and ensure that only authorized personnel can make changes to critical documents and systems.

Training and Competence Management:

  • Training Programs: Develop and implement comprehensive training programs to ensure that personnel are adequately trained for their roles. Regularly assess and update training programs as needed.
  • Competence Assessment: Periodically assess the competence of personnel and provide additional training or support as necessary. Document and maintain records of training and competence assessments.

Supplier and Vendor Management:

  • Supplier Qualification: Establish criteria for supplier qualification and conduct thorough assessments before selecting and engaging with suppliers. Regularly review and audit suppliers to ensure ongoing compliance.
  • Quality Agreements: Develop and maintain quality agreements with suppliers to clearly define roles, responsibilities, and quality expectations.

Product Quality Review (PQR):

  • Data Collection: Collect relevant data on product quality, including manufacturing processes, deviations, and quality control results.
  • Analysis and Assessment: Analyze the collected data to assess product quality trends and identify areas for improvement. Conduct a comprehensive assessment of the overall product quality.
  • Documentation and Reporting: Document the results of the PQR and report findings to relevant stakeholders. Use the information to make informed decisions and implement improvements.

Challenges and Emerging Trends in Pharmaceutical QMS

The pharmaceutical industry operates in a dynamic environment, where continuous advancements and evolving challenges shape the landscape of Quality Management Systems (QMS). Understanding and addressing these challenges, while staying abreast of emerging trends, is crucial for pharmaceutical companies to maintain the highest standards of quality, compliance, and innovation. Here are some key challenges and emerging trends in Pharmaceutical QMS:


Globalization and Supply Chain Complexity:

Challenge: The pharmaceutical supply chain has become increasingly globalized, involving numerous suppliers and manufacturers. Managing the complexity of international supply chains introduces challenges related to quality assurance, regulatory compliance, and risk management.

Mitigation: Implement robust supplier and vendor management practices, conduct thorough audits, and establish clear quality agreements. Ensure compliance with international regulatory standards and maintain visibility and control over the entire supply chain.

Digital Transformation:

Challenge: The integration of digital technologies, including electronic systems and data analytics, presents challenges related to data integrity, cybersecurity, and ensuring the compliance of digital systems with regulatory requirements.

Mitigation: Implement robust data integrity measures, conduct thorough validation of digital systems, and ensure the security of electronic records. Stay informed about evolving digital trends and regulatory expectations.

Advanced Manufacturing Technologies:

Challenge: The adoption of advanced manufacturing technologies, such as continuous manufacturing and 3D printing, introduces complexities in process control, validation, and regulatory alignment.

Mitigation: Stay abreast of regulatory guidance on advanced manufacturing technologies, conduct thorough validation studies, and collaborate with regulatory agencies to ensure alignment with evolving standards.

Focus on Patient-Centricity:

Challenge: A shift towards a more patient-centric approach in the pharmaceutical industry introduces challenges in incorporating patient perspectives into the QMS, including product development, manufacturing, and post-marketing activities.

Mitigation: Engage patients in the development process, consider patient preferences and needs, and incorporate patient-reported outcomes in quality assessments. Align QMS processes with the goal of improving patient experience and outcomes.

Emerging Trends:

Digitalization and Data Analytics:

Trend: The pharmaceutical industry is increasingly leveraging digital technologies, including data analytics, artificial intelligence, and machine learning, to enhance decision-making, optimize processes, and improve overall efficiency.

Impact: Digital tools can provide real-time insights, predictive analytics, and facilitate proactive decision-making. Companies adopting digital solutions can enhance their QMS by leveraging data to drive continuous improvement.

Advanced Quality Risk Management:

Trend: There is a growing emphasis on advanced quality risk management approaches, integrating risk assessment and mitigation strategies into decision-making processes throughout the product lifecycle.

Impact: By adopting a more sophisticated risk management approach, companies can identify potential issues early, make informed decisions, and prioritize resources effectively to mitigate risks and improve overall quality.

Personalized Medicine:

Trend: The trend towards personalized medicine, tailoring treatments to individual patient characteristics, requires adjustments to traditional QMS processes to accommodate the complexities of small-batch, patient-specific production.

Impact: QMS processes need to be flexible to accommodate the unique requirements of personalized medicine, including adaptable manufacturing processes, specialized testing, and a focus on patient-specific quality considerations.

Regulatory Harmonization:

Trend: Efforts toward regulatory harmonization, such as those led by the International Council for Harmonisation (ICH), aim to standardize regulatory requirements globally, reducing redundancy and facilitating global product development and registration.

Impact: Regulatory harmonization streamlines compliance efforts for pharmaceutical companies operating in multiple regions, promoting consistency in QMS processes and facilitating faster access to global markets.

Top Essential Tools for Pharmaceuticals QMS

Pharmaceutical Quality Management Systems (QMS) rely on various tools and technologies to facilitate efficient and compliant operations. These tools help streamline processes, manage documentation, track quality metrics, and ensure continuous improvement. Here are the top five tools commonly used in the pharmaceutical industry for QMS:

Electronic Document Management System (EDMS):

Purpose: An Electronic Document Management System is a software solution designed to create, manage, and control documents electronically.

Key Features:

  • Version Control: Ensures that users access and work with the latest version of documents.
  • Document Workflow: Facilitates the creation, review, approval, and distribution processes electronically.
  • Access Control: Defines roles and permissions, restricting access to sensitive documents.
  • Audit Trail: Maintains a record of document changes for traceability and compliance.


  • Improves document accessibility and retrieval.
  • Enhances version control and reduces the risk of using outdated documents.
  • Facilitates compliance with regulatory requirements for document management.

Quality Management Software (QMS Software):

Purpose: QMS software is a comprehensive solution that helps organizations manage quality-related processes and data.

Key Features:

  • CAPA Management: Tracks and manages Corrective and Preventive Actions.
  • Audit Management: Facilitates internal and external audit processes.
  • Risk Management: Assists in identifying, assessing, and mitigating risks.
  • Training Management: Tracks employee training and competence.
  • Reporting and Analytics: Provides insights into quality metrics and performance.


  • Centralizes quality-related activities in a unified platform.
  • Enhances visibility into quality performance and compliance.
  • Facilitates a closed-loop approach to CAPA management.

Electronic Batch Record (EBR) System:

Purpose: An EBR system replaces traditional paper-based batch records with electronic workflows to document and manage manufacturing processes.

Key Features:

  • Real-time Data Entry: Enables operators to input data electronically during the manufacturing process.
  • Automated Calculations: Reduces manual errors by automating calculations and data processing.
  • Electronic Signatures: Ensures secure and compliant authorization of electronic records.
  • Integration with QMS: Connects with QMS software for seamless quality management.


  • Improves data accuracy and reduces the risk of transcription errors.
  • Enhances real-time visibility into manufacturing processes.
  • Streamlines batch record review and approval processes.

Training Management System:

Purpose: A Training Management System is designed to track and manage employee training and competency.

Key Features:

  • Training Needs Assessment: Identifies training requirements for employees.
  • Course Management: Manages training courses, schedules, and materials.
  • Competence Assessment: Evaluates and records employee competence.
  • Electronic Training Records: Maintains a digital record of training activities.


  • Ensures that employees are adequately trained for their roles.
  • Facilitates compliance with regulatory training requirements.
  • Provides a centralized repository for training records.

Statistical Process Control (SPC) Software:

Purpose: SPC software is used for monitoring and controlling processes to ensure they operate within specified limits.

Key Features:

  • Data Collection and Analysis: Gathers data from manufacturing processes.
  • Control Charts: Visualizes process variability over time.
  • Alerts and Notifications: Notifies users of out-of-spec conditions.
  • Trend Analysis: Identifies patterns and trends in process data.


  • Facilitates early detection of deviations and process variations.
  • Improves overall process control and product quality.
  • Supports a data-driven approach to continuous improvement.

These tools collectively contribute to the efficiency, compliance, and continuous improvement of pharmaceutical QMS processes. When integrated effectively, they help pharmaceutical companies meet regulatory requirements, enhance product quality, and ensure the safety and efficacy of their pharmaceutical products.

Best 5 Tools For Pharmaceutical QMS

Visure Solutions:

Overview: Visure Solutions provides a comprehensive QMS solution tailored for the pharmaceutical and life sciences industries. It is known for its Requirements Management platform, which aids in managing the entire requirements lifecycle, ensuring traceability, and supporting compliance.

Key Features:

  • Requirements Management: End-to-end management of requirements from creation to verification.
  • Traceability: Ensures traceability between requirements, design, testing, and other phases.
  • Risk Management: Integrated risk management capabilities to identify and mitigate potential issues.
  • Change Control: Manages changes to requirements with proper documentation.


  • Industry Focus: Tailored for industries with stringent regulatory requirements.
  • Collaboration: Supports collaboration among cross-functional teams.
  • Audit Trail: Provides a clear audit trail for compliance purposes.

MasterControl QMS:

Overview: MasterControl is a widely used QMS software that offers a suite of modules to manage various quality processes in the pharmaceutical industry. It facilitates document control, training management, CAPA, and more.

Key Features:

  • Document Management: Controls creation, approval, and distribution of documents.
  • Training Management: Tracks employee training and ensures compliance.
  • CAPA Management: Manages corrective and preventive actions with workflow automation.
  • Change Control: Ensures proper control and documentation of changes.


  • Comprehensive Solution: Provides an integrated platform for various QMS processes.
  • Configurability: Adaptable to the specific needs and processes of pharmaceutical companies.
  • Audit-Ready: Helps maintain compliance with regulatory requirements.

Sparta Systems TrackWise:

Overview: TrackWise, by Sparta Systems, is an enterprise quality management software widely used in regulated industries, including pharmaceuticals. It offers modules for quality management, document control, deviation management, and more.

Key Features:

  • Quality Management: End-to-end management of quality processes.
  • Document Management: Ensures proper control and traceability of documents.
  • Deviation Management: Tracks and manages deviations from standard processes.
  • Audit Management: Facilitates internal and external audit processes.


  • Configurable Workflow: Allows companies to tailor processes to their specific needs.
  • Scalability: Suitable for both small and large pharmaceutical enterprises.
  • Integration Capabilities: Connects with other enterprise systems for data consistency.

EtQ Reliance:

Overview: EtQ Reliance is a flexible and scalable QMS solution that addresses various quality and compliance needs. It is designed to support industries with stringent regulatory requirements, including pharmaceuticals.

Key Features:

  • Risk Management: Identifies, assesses, and mitigates risks across processes.
  • Incident Management: Manages incidents, deviations, and non-conformances.
  • Supplier Management: Ensures the quality and compliance of suppliers.
  • Reporting and Analytics: Provide real-time insights into quality metrics.


  • Flexible Configuration: Adapts to the unique processes of pharmaceutical organizations.
  • Scalable Architecture: Scales with the growth of the organization.
  • Mobile Access: Allows access to QMS processes from various devices.

AssurX QMS:

Overview: AssurX offers a QMS solution that includes modules for document management, CAPA, audit management, training management, and more. It is designed to support compliance with various regulatory standards.

Key Features:

  • Document Management: Controls the creation, review, and approval of documents.
  • CAPA Management: Manages corrective and preventive actions with workflow automation.
  • Audit Management: Facilitates internal and external audit processes.
  • Training Management: Ensures employees are adequately trained and competent.


  • Compliance Support: Helps organizations meet regulatory requirements.
  • Configurable Workflow: Adaptable to different business processes.
  • Reporting Capabilities: Provides insights into quality performance.

When selecting a QMS tool for a pharmaceutical environment, it’s crucial to evaluate each tool’s specific features, scalability, and alignment with regulatory requirements. These tools play a crucial role in ensuring that pharmaceutical companies can maintain the highest standards of quality and compliance throughout their processes.


In conclusion, the effective implementation of a robust Quality Management System (QMS) is indispensable for pharmaceutical companies to navigate the intricacies of regulatory compliance, ensure product quality, and drive continuous improvement. Visure Solutions stands out as a comprehensive and industry-focused QMS tool, excelling in requirements management and supporting traceability in adherence to stringent pharmaceutical regulations. Alongside Visure, MasterControl, Sparta Systems TrackWise, EtQ Reliance, and AssurX QMS offer powerful solutions catering to various QMS needs, including document control, training management, CAPA, and risk management. The integration of these tools contributes significantly to the efficiency, scalability, and audit readiness of pharmaceutical operations. For those interested in experiencing Visure Solutions firsthand, a free 30-day trial is available, providing an opportunity to explore its capabilities in optimizing pharmaceutical QMS processes. Take the next step in elevating your quality management – check out the free 30-day trial at Visure today.

Don’t forget to share this post!

IBM Rational Doors Software

Implementing AI Best Practices To Optimize Avionics Requirements

September 12th, 2024

11 am EST | 5 pm CEST | 8 am PST

Fernando Valera

Fernando Valera

CTO, Visure Solutions

Reza Madjidi

Reza Madjidi

CEO, ConsuNova Inc.

An Integrated Approach with Visure Solutions and ConsuNova Inc.

Learn how does AI help in Optimizing Avionics Requirements for Safe Takeoff & Landing